Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible enterobacteriaceae: A case-case-control study

• Main Authors: Teo J., Cai Y., Tang S., Lee W., Tan T.Y., Tan T.T., Kwa A.L.-H.
• Other Authors: DUKE-NUS MEDICAL SCHOOL
• Format: Article
• Published: 2019
• Subjects: amikacin; aminoglycoside; amoxicillin plus clavulanic acid; antibiotic agent; beta lactamase AmpC; carbapenem; cefepime; ceftriaxone; cephalosporin; ciprofloxacin; ertapenem; extended spectrum beta lactamase; gentamicin; penicillin G; piperacillin plus tazobactam; porin; antiinfective agent; beta lactam; carbapenem derivative; adult; aged; antibiotic resistance; antibiotic sensitivity; article; bacterium isolate; carbapenem susceptible Enterobacteriaceae; case control study; clonal variation; comorbidity; controlled study; demography; drug exposure; drug response; Enterobacteriaceae; Enterobacteriaceae infection; ertapenem resistant Enterobacteriaceae; female; hospital patient; hospitalization; human; independent variable; instrumentation; major clinical study; male; molecular epidemiology; mortality; multivariate logistic regression analysis; outcome assessment; retrospective study; risk factor; Singapore; tertiary health care; treatment duration; adolescent; cross infection; drug effect; growth, development and aging; microbiology; middle aged; multidrug resistance; multivariate analysis; statistical model; treatment outcome; Negibacteria; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Female; Humans; Logistic Models; Male; Middle Aged; Molecular Epidemiology; Multivariate Analysis; Risk Factors; Treatment Outcome; Young Adult
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/161993
• Institution: National University of Singapore

10.1371/journal.pone.0034254